Lipomics Partners with Joslin Diabetes Center on Biomarkers | GenomeWeb
NEW YORK (GenomeWeb News) – Lipomics Technologies today said that it is collaborating with the Joslin Diabetes Center on two studies, one of which aims to identify biomarkers for potential diagnostics.
 
The first study, on insulin-resistant patients with a family history of type 2 diabetes, aims to identify predictive markers of diabetes that Lipomics could develop into blood-based diagnostics. The second study will focus on the effects of gastric bypass surgery on insulin sensitivity.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.